Swiss drugmaker Roche Holding plans to test whether an experimental medicine can prevent Alzheimer's disease symptoms in high ...

Posay's Effaclar A.Z. Gel-Cream is touted as a skincare unicorn. But is it really as good as everyone says it is?

The National Health Insurance Authority, Roche Pharmaceuticals and the Federal Medical Centre, Abuja, have launched a cost-sharing initiative to help cancer patients reduce financial barriers to ...

Roche Holding AG plans to test whether an experimental medicine can prevent Alzheimer’s disease symptoms in high-risk people, ...

Roche has added another phase 3 trial in its programme for Alzheimer's disease candidate trontinemab and will now test the ...

Roche’s Alzheimer’s disease therapy has continued to show benefit for patients after 28 weeks in a long-term extension study.

In a Phase Ib/IIa trial, 91% of patients receiving the highest dose of trontinemab were amyloid negative after seven months ...

DPIIT collaborates with Roche Products and HDFC Capital Advisors to support startups in healthcare and affordable housing ...

On July 19, the Yorkshire Post published Roche’s obituary, stating, “Roche, Rosie Jeanne Burke. Died on Monday, 14th July ...

Trontinemab’s Phase Ib/IIa Brainshuttle™ AD study continues to show rapid and robust clearance of amyloid plaques, with 91% ...

In its own communique issued shortly after the FDA’s, Sarepta elaborated on the situation and confirmed a Roche statement to ...

Major health news includes Roche's plan to test a drug for Alzheimer's, a US data-sharing initiative in healthcare, Nordic ...